Nabil Asaad, PhD

Collaborateur senior

Nabil Asaad, PhD

Nabil specialises in IP and regulatory advice for clients ranging from start-ups to global players, with a particular focus on the life sciences and other technology-rich sectors.

Nabil provides pragmatic, commercially-minded advice with a focus on intellectual property strategy and regulatory compliance. In addition to advice on the identification, protection, commercialisation and enforcement of IP rights, Nabil supports clients with commercial contracts, due diligence, and regulatory compliance.

Prior to training as a solicitor, Nabil worked in early phase pharmaceutical R&D for AstraZeneca and chaired the Physical Organic Chemistry Group of the Royal Society of Chemistry.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

ACM
Sciences de la vie et Santé

Dutch competition authority ACM fines pharmaceutical manufacturer €19.5 million over price increases of more than 1800%

22 juillet 2021
Briefing

par Bram Nijhof

Cliquer ici pour en savoir plus
Brevets et innovation

English patent torpedoes and the UPC

19 juillet 2021
Quick read

par Paul England, DPhil

Cliquer ici pour en savoir plus
Brevets et innovation

Anja Lunze comments on the UPC, with insights featured in Bloomberg Law

14 juillet 2021

par Dr. Anja Lunze, LL.M.

Cliquer ici pour en savoir plus
UPC

The Unified Patent Court (“UPC”) and Unitary Patents

13 juillet 2021
In-depth analysis

par plusieurs auteurs

Cliquer ici pour en savoir plus

Autres avocats qui pourraient vous intéresser